AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| ACX | Postscript | 09/04/18 | 6 | 1.0K | |||
|
|||||||
| ACX | Ann: Final Director's Interest Notice - Simon Yencken | 03/04/18 | 0 | 101 | |||
|
|||||||
| ACX | Ann: Final Director's Interest Notice - Rob Phillpot | 03/04/18 | 0 | 57 | |||
|
|||||||
| ACX | Ann: Final Director's Interest Notice - Leigh Jasper | 03/04/18 | 0 | 63 | |||
|
|||||||
| ACX | Ann: Final Director's Interest Notice - Adam Lewis | 03/04/18 | 0 | 57 | |||
|
|||||||
| ACX | Ann: Final Director's Interest Notice - Paul Unruh | 03/04/18 | 0 | 57 | |||
|
|||||||
| ACX | Ann: Final Director's Interest Notice - Rosemary Hartnett | 03/04/18 | 0 | 55 | |||
|
|||||||
| ACX | Ann: Final Director's Interest Notice - Keith Toh | 03/04/18 | 0 | 65 | |||
|
|||||||
See All Discussions
ASX News